#VisualAbstract: Adjunctive D-Cycloserine for transcranial magnetic stimulation can improve treatment-resistant depressive symptoms

byKeerthana Pasumarthi

October 21, 2022

in StudyGraphics

Reading Time: 1 min read

Ruxolitinib results in improved repigmentation as compared to vehicle-control in nonsegmental vitiligo

RelatedReports

Free alternatives comparable to Mini-Mental State Examination

Chronic Disease

Lecanemab may slow cognitive decline in early Alzheimer’s disease

January 10, 2023

Mindfulness-based therapy associated with improvement in quality of life for PTSD patients

Chronic Disease

Intensive outpatient prolonged exposure effective for combat related posttraumatic stress disorder

January 9, 2023

Post-surgical wound complications more common in obese ovarian cancer patients

Weekly Rewinds

2 Minute Medicine Rewind January 9, 2023

January 11, 2023

Children’s hospital visits for suicide ideation and attempts are increasing

Chronic Disease

Significant paternal symptoms of depression and trauma following poor fetal, neonatal, and maternal outcomes

January 7, 2023

#VisualAbstract: Bronchodilators do not improve symptomatic tobacco-exposure in patients with preserved lung function

Post-intensive care syndrome risk in out-of-hospital cardiac arrest patients

Risk factors and rates of post-intensive care syndrome for patients with out-of-hospital cardiac arrest

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

#VisualAbstract: Adjunctive D-Cycloserine for transcranial magnetic stimulation can improve treatment-resistant depressive symptoms

Lecanemab may slow cognitive decline in early Alzheimer’s disease

Intensive outpatient prolonged exposure effective for combat related posttraumatic stress disorder

2 Minute Medicine Rewind January 9, 2023

Ruxolitinib results in improved repigmentation as compared to vehicle-control in nonsegmental vitiligo

#VisualAbstract: Bronchodilators do not improve symptomatic tobacco-exposure in patients with preserved lung function

RelatedReports

Lecanemab may slow cognitive decline in early Alzheimer’s disease

Intensive outpatient prolonged exposure effective for combat related posttraumatic stress disorder

2 Minute Medicine Rewind January 9, 2023

Significant paternal symptoms of depression and trauma following poor fetal, neonatal, and maternal outcomes

#VisualAbstract: Bronchodilators do not improve symptomatic tobacco-exposure in patients with preserved lung function

Post-intensive care syndrome risk in out-of-hospital cardiac arrest patients

Risk factors and rates of post-intensive care syndrome for patients with out-of-hospital cardiac arrest

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2MM+ Premium Access

Recent Reports

Want more physician-written
medical news?

#VisualAbstract: Adjunctive D-Cycloserine for transcranial magnetic stimulation can improve treatment-resistant depressive symptoms

RELATED REPORTS

Ruxolitinib results in improved repigmentation as compared to vehicle-control in nonsegmental vitiligo

#VisualAbstract: Bronchodilators do not improve symptomatic tobacco-exposure in patients with preserved lung function

RelatedReports

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2MM+ Premium Access

Recent Reports

Want more physician-written medical news?

Want more physician-written
medical news?